Optimised dosage of diaminophenothiazines in populations

MYPI2025001037A0Undetermined Publication Date: 2020-01-26WISTA LAB LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025001037
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2019-07-01
Filing Date
2019-07-18
Publication Date
2020-01-26
Patent Text Reader

Abstract

The invention provides novel dosing regimens for Leuco-Methylthioninium (LMT) compounds which maximise the proportion of subjects in which the MT concentration will exceed concentrations in which therapeutic efficacy in relation to treatment of neurodegenerative disorders such as Alzheimer’s disease and frontotemporal dementias can be achieved, while maintaining a desirable clinical profile. Also provided are LMT-containing dosage units and other compositions. Fig. 1
Need to check novelty before this filing date? Find Prior Art